Douglas Dedelow, DO
Obstetrics & Gynecology · Hobart, INNPI 1861492993
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (34.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 45 manufacturers reported payments, led by Acessa Health Inc. at 44.7% of the total. Reporting peaked in 2019 at $8,771 and has fallen 90.7% since, to $818 in 2025. Among obstetrics & gynecology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 265 payments — averaging $60.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acessa Health Inc.$7K
- Stryker$2K
- Coloplast$2K
- AbbVie$1K
- Intuitive Surgical$917
- Bayer$236
- plus $3K from 39 others
What the payments were for
- Consulting fees$5,00031%
- Travel & lodging$5,50035%
- Food & beverage$5,18533%
- Education$2161%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acessa$6,934
- SPY-PHI SYSTEM$1,472
- AXIS$987
- Da Vinci Surgical System$882
- ALTIS$318
- Iris$294
How this compares
$15,902 in reported general payments places this provider in the 95th percentile of 743 obstetrics & gynecology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 26 | $1,773 |
| Metronidazole | 30 | $1,000 |
| Acyclovir | 12 | $537 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 27 | $295 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 13 | $290 |
| Fluconazole | 51 | $157 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $61 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $56 |
| Alendronate Sodium | 20 | $43 |
| Tramadol Hcl | 20 | $36 |
| Ibuprofen | 12 | $15 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Hobart
- Lachanda Dunlap-WrightHobart$8K
- Ashley ScottFort Wayne$124K
- Candace WestgateIndianapolis$123K
- Keith RamseyLake Station$116K
- Stefanie FloraCarmel$106K
- Lori DavidsonGreenwood$54K
- Julius Ellisla Porte$53K
- Emmary ButlerWinchester$45K
- Enrique InfanteElkhart$41K
- Paul MorrisonNewburgh$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.